Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of anti‐interleukin‐13 or anti‐interleukin‐4 agents, compared with placebo, anti‐Immunoglobulin E agents, or anti‐interleukin‐5 agents, for the treatment of children, adolescents...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane database of systematic reviews 2018-01, Vol.2018 (1)
Hauptverfasser:	Edwards, Michaela, Gallagher, Andrew, Nair, Parameswaran, Drew, Stewart, Vyas, Aashish, Sharma, Rashmi, Marsden, Paul A, Evans, David JW
Format:	Artikel
Sprache:	eng
Schlagworte:	Medicine General & Introductory Medical Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of anti‐interleukin‐13 or anti‐interleukin‐4 agents, compared with placebo, anti‐Immunoglobulin E agents, or anti‐interleukin‐5 agents, for the treatment of children, adolescents, or adults with asthma.
ISSN:	1465-1858 1465-1858 1469-493X
DOI:	10.1002/14651858.CD012929